Home/ Stocks/ ADIL

Adial Pharmaceuticals, Inc

ADIL XNAS

$1.43 +0.02 (+1.41%) ▲ 15-min delayed

Open

$1.45

High

$1.49

Low

$1.40

Volume

122.8K

Market Cap

$2.04M

About Adial Pharmaceuticals, Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-7,977,171	$-11.93
FY 2025	$0	$-7,977,171	$-11.93
Q3 2025	$0	$-1,793,651	$-0.08
Q1 2025	$0	$-2,228,801	$-0.34

Related Market News

No specific coverage for ADIL yet. Check out our latest market news or earnings calendar.

Get ADIL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Adial Pharmaceuticals, Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.